Search

Your search keyword '"de Truchis, P."' showing total 386 results

Search Constraints

Start Over You searched for: Author "de Truchis, P." Remove constraint Author: "de Truchis, P."
386 results on '"de Truchis, P."'

Search Results

1. Vision Transformers, a new approach for high-resolution and large-scale mapping of canopy heights

2. High-resolution canopy height map in the Landes forest (France) based on GEDI, Sentinel-1, and Sentinel-2 data with a deep learning approach

3. Global Tracking and Quantification of Oil and Gas Methane Emissions from Recurrent Sentinel-2 Imagery

4. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

5. Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

6. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration

7. EE485 Cost-Effectiveness of a 4 Days-a-Week Triple Therapy in Persons Living with HIV: An Ancillary Study of the Anrs 170 Quatuor Noninferiority Trial

13. Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

18. Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France

20. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

21. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

22. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

24. Native bone and joint infections caused by Extended Spectrum Beta Lactamase (ESBL)-Producing Enterobacterales: experience of a reference center in the Greater Paris area

25. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

29. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

30. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

33. Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

36. HIV Infection and Long‐Term Residual Cardiovascular Risk After Acute Coronary Syndrome

39. Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France

42. Preschool-age children maintain a distinct memory CD4+T cell and memory B cell response after SARS-CoV-2 infection

46. Bacterial diversity and specific taxa are associated with decolonization of carbapenemase-producing enterobacterales after fecal microbiota transplantation.

47. A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers

49. Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

50. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Catalog

Books, media, physical & digital resources